Search

Charanjit Aulakh

Examiner (ID: 11601)

Most Active Art Unit
1625
Art Unit(s)
1625, 1612, 1203, 1621
Total Applications
3765
Issued Applications
2855
Pending Applications
383
Abandoned Applications
582

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 169167 [patent_doc_number] => 07667071 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-23 [patent_title] => 'Process for the preparation of gabapentin hydrochloride' [patent_app_type] => utility [patent_app_number] => 11/990681 [patent_app_country] => US [patent_app_date] => 2006-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4439 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 214 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/667/07667071.pdf [firstpage_image] =>[orig_patent_app_number] => 11990681 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/990681
Process for the preparation of gabapentin hydrochloride Apr 27, 2006 Issued
Array ( [id] => 5705779 [patent_doc_number] => 20060194827 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => '5-Cycloalkenyl 5H-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor modulator compounds' [patent_app_type] => utility [patent_app_number] => 11/411676 [patent_app_country] => US [patent_app_date] => 2006-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19284 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194827.pdf [firstpage_image] =>[orig_patent_app_number] => 11411676 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/411676
5-Cycloalkenyl 5H-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor modulator compounds Apr 24, 2006 Abandoned
Array ( [id] => 4995207 [patent_doc_number] => 20070010552 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'Fluorinated heterocyclic compounds and methods of synthesis' [patent_app_type] => utility [patent_app_number] => 11/410357 [patent_app_country] => US [patent_app_date] => 2006-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6539 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20070010552.pdf [firstpage_image] =>[orig_patent_app_number] => 11410357 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/410357
Fluorinated heterocyclic compounds and methods of synthesis Apr 24, 2006 Abandoned
Array ( [id] => 5678549 [patent_doc_number] => 20060183905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'DERIVATIVES OF 4-(THIO-OR SELENOXANTHENE-9-YLIDENE)-PIPERIDINE OR ACRIDINE AND ITS USE AS A SELECTIVE 5-HT2B RECEPTOR ANTAGONIST' [patent_app_type] => utility [patent_app_number] => 11/379353 [patent_app_country] => US [patent_app_date] => 2006-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10728 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20060183905.pdf [firstpage_image] =>[orig_patent_app_number] => 11379353 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/379353
Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist Apr 18, 2006 Issued
Array ( [id] => 4445408 [patent_doc_number] => 07863447 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-04 [patent_title] => 'Diphosphines and metal complexes' [patent_app_type] => utility [patent_app_number] => 11/887448 [patent_app_country] => US [patent_app_date] => 2006-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10380 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/863/07863447.pdf [firstpage_image] =>[orig_patent_app_number] => 11887448 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/887448
Diphosphines and metal complexes Apr 18, 2006 Issued
Array ( [id] => 5851848 [patent_doc_number] => 20060235039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Hydromorphone polymorphs' [patent_app_type] => utility [patent_app_number] => 11/405286 [patent_app_country] => US [patent_app_date] => 2006-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4058 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20060235039.pdf [firstpage_image] =>[orig_patent_app_number] => 11405286 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/405286
Hydromorphone polymorphs Apr 16, 2006 Issued
Array ( [id] => 5662162 [patent_doc_number] => 20060252758 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => 'Spiroheterocyclic compounds and their uses as therapeutic agents' [patent_app_type] => utility [patent_app_number] => 11/402200 [patent_app_country] => US [patent_app_date] => 2006-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32857 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20060252758.pdf [firstpage_image] =>[orig_patent_app_number] => 11402200 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/402200
Spiroheterocyclic compounds and their uses as therapeutic agents Apr 10, 2006 Issued
Array ( [id] => 131964 [patent_doc_number] => 07700641 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-20 [patent_title] => 'Spiro-oxindole compounds and their uses as therapeutic agents' [patent_app_type] => utility [patent_app_number] => 11/402310 [patent_app_country] => US [patent_app_date] => 2006-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 144383 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/700/07700641.pdf [firstpage_image] =>[orig_patent_app_number] => 11402310 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/402310
Spiro-oxindole compounds and their uses as therapeutic agents Apr 10, 2006 Issued
Array ( [id] => 583334 [patent_doc_number] => 07449490 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-11 [patent_title] => 'Pharmaceutically active compounds and methods of use' [patent_app_type] => utility [patent_app_number] => 11/402240 [patent_app_country] => US [patent_app_date] => 2006-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32558 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/449/07449490.pdf [firstpage_image] =>[orig_patent_app_number] => 11402240 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/402240
Pharmaceutically active compounds and methods of use Apr 10, 2006 Issued
Array ( [id] => 10870544 [patent_doc_number] => 08895742 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-25 [patent_title] => 'Metal-mediated reversible self-assembly of carbon nanotubes' [patent_app_type] => utility [patent_app_number] => 11/910772 [patent_app_country] => US [patent_app_date] => 2006-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 19 [patent_no_of_words] => 4137 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11910772 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/910772
Metal-mediated reversible self-assembly of carbon nanotubes Apr 6, 2006 Issued
Array ( [id] => 5324554 [patent_doc_number] => 20090062544 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'Crystals of Morphinan Derivative and Process for Producing the Same' [patent_app_type] => utility [patent_app_number] => 11/887842 [patent_app_country] => US [patent_app_date] => 2006-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4473 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062544.pdf [firstpage_image] =>[orig_patent_app_number] => 11887842 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/887842
Crystals of morphinan derivative and process for producing the same Apr 5, 2006 Issued
Array ( [id] => 5673035 [patent_doc_number] => 20060178390 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => '1,3,8-Triazaspiro[4,5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders' [patent_app_type] => utility [patent_app_number] => 11/398239 [patent_app_country] => US [patent_app_date] => 2006-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22412 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20060178390.pdf [firstpage_image] =>[orig_patent_app_number] => 11398239 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/398239
1,3,8-Triazaspiro[4,5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders Apr 4, 2006 Abandoned
Array ( [id] => 7691393 [patent_doc_number] => 20070232640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'Antifungal and antiparasitic indoloquinoline derivates' [patent_app_type] => utility [patent_app_number] => 11/394158 [patent_app_country] => US [patent_app_date] => 2006-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7748 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20070232640.pdf [firstpage_image] =>[orig_patent_app_number] => 11394158 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/394158
Antifungal and antiparasitic indoloquinoline derivates Mar 30, 2006 Issued
Array ( [id] => 5609179 [patent_doc_number] => 20060270695 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'Spirocyclic heterocyclic derivatives and methods of their use' [patent_app_type] => utility [patent_app_number] => 11/393133 [patent_app_country] => US [patent_app_date] => 2006-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 176966 [patent_no_of_claims] => 279 [patent_no_of_ind_claims] => 33 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20060270695.pdf [firstpage_image] =>[orig_patent_app_number] => 11393133 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/393133
Spirocyclic heterocyclic derivatives and methods of their use Mar 29, 2006 Issued
Array ( [id] => 5667679 [patent_doc_number] => 20060173029 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'Oxycodone hydrochloride having less than 25 ppm 14- hydroxycodeinone' [patent_app_type] => utility [patent_app_number] => 11/391897 [patent_app_country] => US [patent_app_date] => 2006-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17661 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20060173029.pdf [firstpage_image] =>[orig_patent_app_number] => 11391897 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/391897
Oxycodone hydrochloride having less than 25 ppm 14- hydroxycodeinone Mar 28, 2006 Abandoned
Array ( [id] => 5754659 [patent_doc_number] => 20060223808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-05 [patent_title] => 'Spirocyclic thrombin receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/392324 [patent_app_country] => US [patent_app_date] => 2006-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15136 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20060223808.pdf [firstpage_image] =>[orig_patent_app_number] => 11392324 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/392324
Spirocyclic thrombin receptor antagonists Mar 28, 2006 Issued
Array ( [id] => 486882 [patent_doc_number] => 07217822 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-15 [patent_title] => 'Process for making cabergoline' [patent_app_type] => utility [patent_app_number] => 11/377397 [patent_app_country] => US [patent_app_date] => 2006-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3157 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/217/07217822.pdf [firstpage_image] =>[orig_patent_app_number] => 11377397 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/377397
Process for making cabergoline Mar 16, 2006 Issued
Array ( [id] => 4728149 [patent_doc_number] => 20080207693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Mitotic Kinesin Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/886282 [patent_app_country] => US [patent_app_date] => 2006-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25366 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207693.pdf [firstpage_image] =>[orig_patent_app_number] => 11886282 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/886282
Mitotic Kinesin Inhibitors Mar 9, 2006 Abandoned
Array ( [id] => 5172456 [patent_doc_number] => 20070072889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'Hydrocodone polymorphs' [patent_app_type] => utility [patent_app_number] => 11/371377 [patent_app_country] => US [patent_app_date] => 2006-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2699 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20070072889.pdf [firstpage_image] =>[orig_patent_app_number] => 11371377 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/371377
Hydrocodone polymorphs Mar 7, 2006 Issued
Array ( [id] => 5576224 [patent_doc_number] => 20090143586 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'Method for producing alkyl-substituted aromatic and heteroaromatic compounds by cross-coupling alkyl boronic acids with aryl-or heteroaryl-halogenides or sulfonates under Pd catalysis in the presence of a ligand' [patent_app_type] => utility [patent_app_number] => 11/817820 [patent_app_country] => US [patent_app_date] => 2006-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3257 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20090143586.pdf [firstpage_image] =>[orig_patent_app_number] => 11817820 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/817820
Method for producing alkyl-substituted aromatic and heteroaromatic compounds by cross-coupling alkyl boronic acids with aryl-or heteroaryl-halogenides or sulfonates under Pd catalysis in the presence of a ligand Mar 6, 2006 Abandoned
Menu